To Download a copy of the presentation click here.
To Download a copy of the Q&A Responses here.
For more information on this topic, please visit the Real Time Learning Network
*This call was funded by a cooperative agreement with the Centers for Disease Control and Prevention (grant number NU50CK000574). The Centers for Disease Control and Prevention is an agency within the Department of Health and Human Services (HHS). The contents of this call does not necessarily represent the policy of CDC or HHS, and should not be considered an endorsement by the Federal Government.
Moderator:
Dana S. Wollins, DrPH, MGC
Vice President, Clinical Affairs & Practice Guidelines, IDSA
Topics and Featured Experts
Update on Ebola
Mary Choi, MD, MPH
Lieutenant Commander, U.S. Public Health Service
U.S. Centers for Disease Control & Prevention
Influenza, RSV & COVID-19 — Current State of Play & Considerations for Treatment
Influenza Update
Tim Uyeki, MD, MPH, MPP
Chief Medical Officer
Influenza Division
U.S. Centers for Disease Control and Prevention
RSV Update
Meredith McMorrow, MD
Medical Officer
U.S. Centers for Disease Control and Prevention
Use of COVID-19 Convalescent Plasma
Carlos H. Villa, MD, PhD
Associate Director for Special Programs
Center for Biologics Evaluation and Research
Office of Blood Research and Review
U.S. Food and Drug Administration
Masking to Prevent RTI Transmission in Health Care Settings
Alex J. Kallen, MD, MPH
Chief of the Prevention and Response Branch
Division of Healthcare Quality Promotion
U.S. Centers for Disease Control & Prevention
Chanu Rhee, MD, MPH, FIDSA
Associate Professor, Population Medicine
Harvard Medical School and Harvard Pilgrim Health Care Institute
Associate Hospital Epidemiologist
Brigham and Women's Hospital
Meghan A. Baker, MD, ScD, FIDSA
Assistant Professor, Population Medicine
Harvard Medical School and Harvard Pilgrim Health Care Institute
Associate Hospital Epidemiologist
Brigham and Women's Hospital
